Permanent decrease in activity of ornithine decarboxylase antizyme in rat liver during chemical hepatocarcinogenesis.

Area of Science:

• Biochemistry
• Hepatology
• Carcinogenesis

Background:

• L-ornithine decarboxylase (ODC) activity is a key regulator of cell proliferation.
• ODC activity is primarily controlled by its natural intracellular inhibitor, ODC antizyme.
• Hepatocarcinogenesis involves alterations in cellular regulatory mechanisms.

Purpose of the Study:

• To investigate the role of ODC antizyme in cellular control during azo-dye-induced hepatocarcinogenesis in rats.
• To determine if ODC antizyme levels are altered in preneoplastic and neoplastic liver tissues.
• To elucidate the mechanism behind dysregulated ODC activity in liver cancer.

Main Methods:

• Induction of hepatocarcinogenesis in rats using 3'-methyl-4-dimethylaminoazobenzene.
• Monthly measurement of hepatic ornithine decarboxylase and ornithine decarboxylase antizyme activities over five months.
• Administration of putrescine to assess antizyme formation capacity in normal and cancerous liver tissues.

Main Results:

• Hepatic ODC antizyme activity was significantly lower in azo-dye-induced hepatocarcinogenesis and fully developed hepatoma compared to normal liver.
• The lowest levels of ODC antizyme activity were observed at the second and third months of carcinogenesis.
• Lengthening the time for antizyme formation did not restore ODC antizyme levels in hepatoma, indicating a synthetic defect.

Conclusions:

• The study suggests a failure in cellular control of ODC activity during hepatocarcinogenesis due to a reduced ability of preneoplastic/neoplastic cells to synthesize ODC antizyme.
• High intracellular putrescine levels in cancerous livers do not effectively inhibit ODC activity because of insufficient antizyme production.
• This impaired antizyme synthesis represents a critical mechanism contributing to ODC dysregulation in liver cancer development.